Ultra-Low Volume, High-Throughput Gene Therapy Quality Analysis
Aura GT™ helps you realize the promise of gene therapies, without using a lot of your viral vector sample throughout the development process. Avoid conditions and formulations that facilitate viral vector aggregates, monitor DNA leakage, and ensure product quality with just 5 µL of sample per data point. Use Fluorescence Membrane Microscopy (FMM) and Backgrounded Imaging (BMI) technology to get accurate and quantitative particle size, count, morphology, and ID info. Avoid adverse immunogenetic events that can arise due to subvisible particles (SVPs) and measure the stability of the capsid to determine the shelf-life and efficacy of your product – with just 5 µL!